UK approves chimeric embryos

A British regulatory agency this week granted two universities permission to develop human-animal linkurl:hybrid embryos;http://www.the-scientist.com/article/display/22210/ for stem cell research. Scientists intend to use the embryos, developed from human DNA in linkurl:non-human mammalian eggs,;http://www.the-scientist.com/article/display/15405 for neurodegenerative and diabetes research. According to a linkurl:statement;http://www.hfea.gov.uk/en/377.html from Britain's Human Fertilsation and

kerry grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
A British regulatory agency this week granted two universities permission to develop human-animal linkurl:hybrid embryos;http://www.the-scientist.com/article/display/22210/ for stem cell research. Scientists intend to use the embryos, developed from human DNA in linkurl:non-human mammalian eggs,;http://www.the-scientist.com/article/display/15405 for neurodegenerative and diabetes research. According to a linkurl:statement;http://www.hfea.gov.uk/en/377.html from Britain's Human Fertilsation and Embryology Authority, applications from Kings College London and Newcastle University "satisfied all the requirements of the law," and researchers were granted a one-year license to develop the embryos. Human embryonic stem cell research using oocytes is legal in Britian, a 2007 linkurl:report;http://www.nature.com/ncb/journal/v9/n9/full/ncb436.html in __Nature Cell Biology__ said, "...but the shortage of donated human oocytes has prompted the search for an alternative, hence the idea of using animal eggs." A hat tip to the __Chronicle of Higher Education's__ linkurl:News Blog.;http://chronicle.com/news/article/3771/animal-human-hybrid-embryos-are-approved-in-britain
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • kerry grens

    Kerry Grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours